Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Parkinson's Disease: Risk Assessment of Persistent Delirium and Its Management

NCT05437458 is registered in ClinicalTrials.gov with Newcastle University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05437458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Parkinson's Disease: Risk Assessment of Persistent Delirium and Its Management
Lead sponsor
Newcastle University
Phase
Observational
Overall status
Unknown status
Start date
February 6, 2022
Completion date
September 30, 2025
Enrollment
217 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium in old age, parkinson disease